Cover Image
市場調查報告書

醫療圖像分析軟體的全球市場:考察,機會,分析,市場佔有率,未來預測

Global Medical Imaging Analysis Software Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 473405
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
醫療圖像分析軟體的全球市場:考察,機會,分析,市場佔有率,未來預測 Global Medical Imaging Analysis Software Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022
出版日期: 2017年03月10日 內容資訊: 英文 140 Pages
簡介

本報告提供醫療影像分析用軟體的全球市場相關分析,調查技術、市場概要和最新趨勢,主要市場促進、阻礙因素,市場機會、課題,各類軟體、影像的各類型、各種模式、各終端用戶、各用途及各地區的市場趨勢預測 (過去3年、今後7年份),競爭情形,策略建議,市場發展的方向性,主要企業簡介、策略等。

第1章 簡介

第2章 市場概要

  • 醫療圖像分析軟體市場:發展與變遷
  • 產業結構
  • 製造工程
  • 法規結構
  • 市場整體分析
  • 市場估計分析
  • 策略分析
    • 投資/引進模式
    • 全方位性的產業分析
    • 波特的五力分析
    • Seesaw分析
    • 消費者分析與主要購買標準
    • 差距分析
  • 市場競爭分析
    • 市場佔有率分析
    • 主要企業分析
  • 策略性建議主要的結論
    • 各地區的市場機會
    • 在新領域的市場機會
    • 急速成長市場上的投資機會

第3章 市場決策要素

  • 推動市場要素與其影響
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第4章 市場區隔

  • 醫療圖像分析軟體市場:各類軟體
    • 市場定義和範圍
    • 決策依據的資料庫及估計手法
    • 市場間比較分析
    • 市場機會矩陣
    • 市場區隔:各類軟體 (以金額為準,總計10年份)
      • 一體型軟體
      • 獨立型軟體
  • 醫療圖像分析軟體市場:各影像
    • 市場區隔:影像的各類型 (以金額為準,總計10年份)
      • 2D成像 (二維影像)
      • 3D成像 (三維影像)
      • 4D成像 (四維影像)
  • 醫療圖像分析軟體市場:各種模式
    • 市場區隔:各種模式 (以金額為準,總計10年份)
      • 斷層診斷 (CT)
      • 超音波影像
      • 核子醫學攝影
      • 並用方式 (複合模式)
  • 醫療圖像分析軟體市場:各終端用戶
    • 市場區隔:各終端用戶 (以金額為準,總計10年份)
      • 醫院
      • 診斷中心
      • 研究中心
  • 醫療圖像分析軟體市場:各用途
    • 市場區隔:各用途 (以金額為準,總計10年份)
      • 眼科
      • 牙科
      • 神經科
      • 循環系統科
      • 腫瘤科
      • 肥胖症、婦產科
      • 乳房X光攝影
      • 泌尿科、腎臟病

第5章 競爭環境

  • 主要策略
    • 企業合併、收購 (M&A)的一覽
    • 合資企業 (JV)的一覽
    • 產品銷售的一覽
    • 產業聯盟的一覽
  • 前十大企業分析

第6章 各地區分析

  • 決策依據的資料庫及估計手法
  • 市場間比較分析
  • 市場機會矩陣
  • 市場區隔:各地區 (以金額為準,總計10年份)
    • 北美市場
    • 歐洲市場
    • 亞太地區市場
    • 其他的國家 (RoW)

第7章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HHE-4600317

Global Medical Imaging Analysis Software Market is anticipated to reach US $3,335.3 million with an attractive CAGR of 8.2% during 2016 - 2022. The major drivers which are enhancing the global medical imaging analysis software market are due to rising due to rapid increase in demand for technically progression market for imaging devices, a lot of investment in medical imaging technologies, increasing geriatric population, due to increasing huge number of enduring research activities and growth in the number of new and advanced products being launched in developing Asian countries. Apart from this, some of the factors which are hampering the market are absence of technical and skilled professionals and due to increasing hacking concerns.

The medical imaging analysis software market is segmented on the basis of software, image, modality, application and end-user. According to software segment, the market is further segmented such as integrated software and standalone software. On the basis of image segment, the market is further subdivided into 2D imaging, 3D imaging, and 4D imaging. On the basis of modality segment, the market is further divided into tomography (Computed Tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) and single-photon emission tomography (SPECT)), ultrasound imaging, radiographic imaging, and combined modalities. On the basis, of application segment, the market is further subdivided into orthopedic application, dental applications, neurology, cardiology application, oncology applications, oncology applications, mammography applications and urology and nephrology applications. On the basis of end-user segment, the market is further subdivided into hospitals, diagnostic centers, and research centers.

On the basis of geography, the global medical imaging analysis software market is segmented into four major regions such as North America, APAC, Europe and ROW. Currently, North America is accounted to be the largest market share nearly 35% for medical image analysis software due to huge demand for post-diagnostic treatment and better detection. Asia Pacific is a forthcoming market because of rise in per capita income and technological advancements in diagnostic technology. Asia Pacific is projected to be growing upward at the fastest CAGR of over 9.5% during the prediction period due to the increasing saturation of the medical imaging systems in fast developing economies of the Asia Pacific region, such as India and China. Along with this, there are many of the further driving factors that are promoting overall growth of the market such as high R&D intensity by the major market players, investments in the healthcare industry.

There are many key manufacturing companies which are engaged in Esaote S.p.A (Italy), Agfa healthcare (Belgium), Carestream Health, Inc. (U.S.), Aquilab (France), GE Healthcare (U.K.), MIM Software Inc. (U.S.), Philips Healthcare (Netherlands), Merge Healthcare, Inc. (U.S.), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan). One of the top most manufacturing company 'Philips Healthcare" has launched a new advanced diagnostic equipment which has been developed and designed at its one of the two R&D centers which one of them in India (Pune). One of the two products exposed, which are the mobile diagnost opta, one of them, digital X-Ray system is for limited spaces like rigorous care units and operations theatres. Other than that, BV Vectra is a mobile C-arm system devoted to orthopaedic surgical procedures.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. MARKET SCOPE

2. MARKET OVERVIEW

  • 2.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET: EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. MANUFACTURING PROCESS
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    • 2.7.6. GAP ANALYSIS
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. MARKET SHARE ANALYSIS
    • 2.8.2. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. TECHNOLOGICAL DEVELOPMENTS IN MEDICAL IMAGING SYSTEMS AND ANALYSIS SOFTWARE
    • 3.1.2. INCREASING PUBLIC AND PRIVATE SECTOR INVESTMENTS IN THE MEDICAL IMAGING MARKET
    • 3.1.3. RISING APPLICATIONS OF COMPUTER-AIDED DIAGNOSIS (CAD)
    • 3.1.4. GROWING USAGE OF IMAGING EQUIPMENT
    • 3.1.5. GROWING INCIDENCES OF CHRONIC DISEASES
    • 3.1.6. INCREASE IN FLEXIBILITY
    • 3.1.7. RAPID GROWTH IN AGING POPULATION
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. ABSENCE OF SKILLED PROFESSIONALS
    • 3.2.2. INCREASING SOFTWARE HACKING CONCERNS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. CLOUD-BASED IMAGE ANALYSIS SOLUTIONS
    • 3.3.2. EXPANSION IN DEVELOPING MARKETS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. MARKET PENETRATION OF STANDALONE SOFTWARE VENDORS
    • 3.4.2. HIGH COST OF SOFTWARE

4. MARKET SEGMENTATION

  • 4.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION BY SOFTWARE 2014-2023 ($ MILLION)
      • 4.1.5.1. INTEGRATED SOFTWARE
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. APPLICATION
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.1.5.1.6. KEY CONCLUSIONS
      • 4.1.5.2. STANDALONE SOFTWARE
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. APPLICATION
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.1.5.2.6. KEY CONCLUSIONS
  • 4.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION BY IMAGE 2014-2023 ($ MILLION)
      • 4.2.5.1. 2D IMAGING
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.3. APPLICATION
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.2.5.1.6. KEY CONCLUSIONS
      • 4.2.5.2. 3D IMAGING
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.3. APPLICATION
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.2.5.2.6. KEY CONCLUSIONS
      • 4.2.5.3. 4D IMAGING
        • 4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.3. APPLICATION
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.2.5.3.6. KEY CONCLUSIONS
  • 4.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION BY MODALITY 2014-2023 ($ MILLION)
      • 4.3.5.1. TOMOGRAPHY
        • 4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.3. APPLICATION
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.1.6. KEY CONCLUSIONS
      • 4.3.5.2. ULTRASOUND IMAGING
        • 4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.3. APPLICATION
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.2.6. KEY CONCLUSIONS
      • 4.3.5.3. RADIOGRAPHIC IMAGING
        • 4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.3. APPLICATION
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.3.6. KEY CONCLUSIONS
      • 4.3.5.4. COMBINED MODALITIES
        • 4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.3. APPLICATION
        • 4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.3.5.4.6. KEY CONCLUSIONS
  • 4.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END USER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION BY END-USER 2014-2023 ($ MILLION)
      • 4.4.5.1. HOSPITALS
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. APPLICATION
        • 4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.4.5.1.6. KEY CONCLUSIONS
      • 4.4.5.2. DIAGNOSTIC CENTERS
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. APPLICATION
        • 4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.4.5.2.6. KEY CONCLUSIONS
      • 4.4.5.3. RESEARCH CENTERS
        • 4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.3. APPLICATION
        • 4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.4.5.3.6. KEY CONCLUSIONS
  • 4.5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION
    • 4.5.1. MARKET DEFINITION AND SCOPE
    • 4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.5.4. OPPORTUNITY MATRIX
    • 4.5.5. MARKET SEGMENTATION BY APPLICATION 2014-2023 ($ MILLION)
      • 4.5.5.1. ORTHOPEDIC APPLICATIONS
        • 4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.1.3. APPLICATION
        • 4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.1.6. KEY CONCLUSIONS
      • 4.5.5.2. DENTAL APPLICATIONS
        • 4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.2.3. APPLICATION
        • 4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.2.6. KEY CONCLUSIONS
      • 4.5.5.3. NEUROLOGY
        • 4.5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.3.3. APPLICATION
        • 4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.3.6. KEY CONCLUSIONS
      • 4.5.5.4. CARDIOLOGY APPLICATIONS
        • 4.5.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.4.3. APPLICATION
        • 4.5.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.4.6. KEY CONCLUSIONS
      • 4.5.5.5. ONCOLOGY APPLICATIONS
        • 4.5.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.5.3. APPLICATION
        • 4.5.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.5.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.5.6. KEY CONCLUSIONS
      • 4.5.5.6. OBSTETRICS AND GYNECOLOGY APPLICATIONS
        • 4.5.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.6.3. APPLICATION
        • 4.5.5.6.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.6.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.6.6. KEY CONCLUSIONS
      • 4.5.5.7. MAMMOGRAPHY APPLICATIONS
        • 4.5.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.7.3. APPLICATION
        • 4.5.5.7.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.7.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.7.6. KEY CONCLUSIONS
      • 4.5.5.8. UROLOGY AND NEPHROLOGY APPLICATIONS
        • 4.5.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.8.3. APPLICATION
        • 4.5.5.8.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.8.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
        • 4.5.5.8.6. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. RUSSIA
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. . AGFA-GEVAERT GROUP
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION/FOCUS SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
  • 7.2. AQUILAB
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION/FOCUS SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
  • 7.3. BARCO
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION/FOCUS SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
  • 7.4. BRUKER
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION/FOCUS SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
  • 7.5. CARESTREAM HEALTH, INC.
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION/FOCUS SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. ELEKTA
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION/FOCUS SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
  • 7.7. ESAOTE S.P.A
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION/FOCUS SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
  • 7.8. GENERAL ELECTRIC COMPANY (GE)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION/FOCUS SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
  • 7.9. INFIMED
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION/FOCUS SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
  • 7.10. MERGE HEALTHCARE INC.
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION/FOCUS SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
  • 7.11. MIM SOFTWARE, INC.
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION/FOCUS SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
  • 7.12. PHILIPS HEALTHCARE
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION/FOCUS SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
  • 7.13. SIEMENS HEALTHCARE
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION/FOCUS SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
  • 7.14. TOSHIBA MEDICAL SYSTEMS CORPORATION
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION/FOCUS SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
  • 7.15. XINAPSE SYSTEMS LTD.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION/FOCUS SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS

LIST OF TABLES

  • 1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE 2014-2023 ($ MILLION)
  • 2. GLOBAL INTEGRATED SOFTWARE BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL STANDALONE SOFTWARE BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE 2014-2023 ($ MILLION)
  • 5. GLOBAL 2D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL 3D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL 4D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY 2014-2023 ($ MILLION)
  • 9. GLOBAL TOMOGRAPHY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL ULTRASOUND IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL RADIOGRAPHIC IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL COMBINED MODALITIES BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 13. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END-USER 2014-2023 ($ MILLION)
  • 14. GLOBAL HOSPITALS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL DIAGONAL CENTERS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. GLOBAL RESEARCH CENTERS BY GEOGRAPHY 2014-202 3($ MILLION)
  • 17. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 18. GLOBAL ORTHOPEDIC APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 19. GLOBAL DENTAL APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL NEUROLOGY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. GLOBAL CARDIOLOGY APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 22. GLOBAL ONCOLOGY APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 23. GLOBAL OBSTETRICS AND GYNECOLOGY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 24. GLOBAL MAMMOGRAPHY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 25. GLOBAL UROLOGY AND NEPHROLOGY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 26. NORTH AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 27. EUROPE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 28. ASIA PACIFIC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 29. REST OF THE WORLD MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY UROLOGY AND NEPHROLOGY APPLICATIONS 2016-2023 ($ MILLION)
  • 2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAMMOGRAPHY APPLICATIONS 2016-2023 ($ MILLION)
  • 3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OBSTETRICS AND GYNECOLOGY APPLICATIONS 2016-2023 ($ MILLION)
  • 4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ONCOLOGY APPLICATION 2016-2023 ($ MILLION)
  • 5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CARDIOLOGY APPLICATION 2016-2023 ($ MILLION)
  • 6. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY NEUROLOGY 2016-2023 ($ MILLION)
  • 7. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DENTAL APPLICATIONS 2016-2023 ($ MILLION)
  • 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ORTHOPEDIC APPLICATION 2016-2023 ($ MILLION)
  • 9. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HOSPITALS 2016-2023 ($ MILLION)
  • 10. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DIAGONALS CENTERS 2016-2023 ($ MILLION)
  • 11. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RESEARCH CENTERS 2016-2023 ($ MILLION)
  • 12. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY TOMOGRAPHY 2016-2023 ($ MILLION)
  • 13. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ULTRASOUND IMAGING 2016-2023 ($ MILLION)
  • 14. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RADIOGRAPHIC IMAGING 2016-2023 ($ MILLION)
  • 15. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMBINED MODALITIES 2016-2023 ($ MILLION)
  • 16. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D 2016-2023 ($ MILLION)
  • 17. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D 2016-2023 ($ MILLION)
  • 18. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 4D 2016-2023 ($ MILLION)
  • 19. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY INTEGRATED SOFTWARE 2016-2023 ($ MILLION)
  • 20. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY STANDALONE SOFTWARE 2016-2023 ($ MILLION)
  • 21. UNITED STATES (U.S.) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 22. CANADA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 23. UNITED KINGDOM (UK) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 24. FRANCE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 25. GERMANY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 26. SPAIN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 27. ITALY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 28. ROE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 29. INDIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 30. CHINA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 31. JAPAN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 32. KOREA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 33. AUSTRALIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 34. ROAPAC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 35. LATIN AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 36. MENA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
Back to Top